© Drug Hunter Inc. 2018-2023
Home > “compound 27”
potent pan-PIM kinase inhibitor
oral PD and efficacy in xenograft model
from SBDD of prior lead
Bioorg. Med. Chem. Lett., Oct. 14, 2020
Sanofi, Waltham/Cambridge, MA
“compound 27” (Sanofi oral in vivo pan-PIM kinase inhibitor)
Drug Hunter is commited to helping industry innovators make informed decisions. Premium members have access to our library of the latest stories in science, written by scientists.
Request a trial to access insights powering the pros in our industry.
Molecules of the Month
Molecule of the Year